Fresh Frozen Facts Part 3: A Thoughtful Look at Plasma Transfusion by Dr. Caitlin Raymond
Caitlin Raymond, MD/PhD shared an insightful chain of posts on LinkedIn:
”Fresh Frozen Facts, Part III: What FFP Doesn’t Do and Alternatives
Plasma transfusion isn’t benign. And too often, it isn’t necessary.
In Part III of my four-part series on plasma products, I dive into one of the most common — and most misguided — uses in transfusion medicine: the reflexive ordering of FFP in moments of clinical uncertainty.
- Mild INR elevation before a procedure?
- Confusing coagulopathy in a bleeding patient?
- A vague feeling that “we should do something”?
For years, that “something” has too often been FFP — despite evidence that it’s ineffective, high-risk, and rarely the right tool for the job. This post breaks down:
- Why plasma won’t correct a mildly elevated INR
- The truth about coagulopathy in liver disease
- Why FFP is not a volume expander
- Better alternatives: PCCs, cryo, vitamin K, platelets, and targeted factor concentrates
I also tackle the risks we often overlook: TRALI, TACO, allergic reactions, and the resource burden of thawing, typing, and administering plasma when it won’t help.
If you’ve ever wondered when not to transfuse — or how to avoid “just in case” medicine — this one’s for you.”
Read the full poste here.
Caitlin Raymond, MD/PhD, has launched an educational series on Fresh Frozen Plasma (FFP), now available on her journal blog.
Enjoy the third part and make sure you do not miss all the Fresh Frozen Facts!
Stay tuned for updates to the Fresh Frozen Facts series on Hemostasis Today.
-
Jul 31, 2025, 16:43Jason S Knight: Antiphospholipid Syndrome Review
-
Jul 31, 2025, 16:28William McKeown: Once or Twice Weekly Altuvoct? Insights
-
Jul 31, 2025, 16:07Thomas Reiser: Submit Your Research to JTH and RPTH
-
Jul 31, 2025, 15:56eJHaem Publication and MATRON Audit Spotlight Gaps in Pulmonary Embolism Care for Pregnant Patients
-
Jul 31, 2025, 15:50Alfadil Haroon on Inherited Platelet Disorders: Know The Basics
-
Jul 31, 2025, 16:12Samin Mohsenian Shares the Final Open Access Version: Ob/Gyn Complications and Congenital Fibrinogen Disorders
-
Jul 31, 2025, 15:45Tzu-Fei Wang: To Anticoagulate or Not To Anticoagulate—That Is The Question
-
Jul 31, 2025, 15:12Wolfgang Miesbach: Protecting Liver Health in Bleeding Disorders
-
Jul 30, 2025, 16:24Cedric Hermans Invites You to Explore Hematologie Edition 2025 Nº 04
-
Jul 30, 2025, 15:53Robert Sidonio on the Role of aPCC in Patients Receiving Emicizumab Prophylaxis
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Jul 26, 2025, 17:56HIPEITHO Trial Achieves Remarkable Enrollment Milestone Across 72 Sites in the US and Europe
-
Jul 16, 2025, 15:04Toward Hemophilia Gene Therapy for All? Insights from Prof. Flora Peyvandi in Blood Advances
-
Jul 14, 2025, 16:39Dr. Philipp Bücke: MRI Proven as No.1 Choice for Accurate TIA Diagnosis
-
Jul 13, 2025, 16:05EMA and HMA Mark a Key Step with 1st AI Observatory Report
-
Jul 31, 2025, 15:37Sano Genetics: “Unreasonable” Leadership with Benny Sorenson of Hemab
-
Jul 28, 2025, 12:53Zambia’s Hemophilia Prophylaxis Success
-
Jul 26, 2025, 16:14Cesar Garrido: Forging Strong Partnerships on WHA78 ''Global Health Equity'' Event
-
Jul 23, 2025, 15:34Don't Miss the Hemophilia B Virtual Event on July 29 – Sign Up Now!
-
Jul 23, 2025, 11:05Haemnet Gives Voice to Parents Facing the Challenges of Childhood Bleeding Disorders